Joseph Lee Grant Matheson - Net Worth and Insider Trading
Joseph Lee Grant Matheson Net Worth
The estimated net worth of Joseph Lee Grant Matheson is at least $935,958 dollars as of 2024-12-12. Joseph Lee Grant Matheson is the Director of Knight Therapeutics Inc and owns about 108,600 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $573,408. Joseph Lee Grant Matheson is the Director of AutoCanada Inc and owns about 15,000 shares of AutoCanada Inc (TSX:ACQ) stock worth over $287,550. Joseph Lee Grant Matheson is also the Director of Optiva Inc and owns about 25,000 shares of Optiva Inc (TSX:OPT) stock worth over $75,000. Details can be seen in Joseph Lee Grant Matheson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Lee Grant Matheson has not made any transactions after 2022-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Lee Grant Matheson
Joseph Lee Grant Matheson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Lee Grant Matheson owns 3 companies in total, including Knight Therapeutics Inc (TSX:GUD) , Optiva Inc (TSX:OPT) , and AutoCanada Inc (TSX:ACQ) .
Click here to see the complete history of Joseph Lee Grant Matheson’s form 4 insider trades.
Insider Ownership Summary of Joseph Lee Grant Matheson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-09 | Director |
| TSX:OPT | Optiva Inc | 2021-11-29 | Director |
| TSX:ACQ | AutoCanada Inc | 2022-03-08 | Director |
Joseph Lee Grant Matheson Latest Holdings Summary
Joseph Lee Grant Matheson currently owns a total of 3 stocks. Among these stocks, Joseph Lee Grant Matheson owns 108,600 shares of Knight Therapeutics Inc (TSX:GUD) as of August 9, 2019, with a value of $573,408 and a weighting of 61.26%. Joseph Lee Grant Matheson owns 15,000 shares of AutoCanada Inc (TSX:ACQ) as of March 8, 2022, with a value of $287,550 and a weighting of 30.72%. Joseph Lee Grant Matheson also owns 25,000 shares of Optiva Inc (TSX:OPT) as of November 29, 2021, with a value of $75,000 and a weighting of 8.01%.
Latest Holdings of Joseph Lee Grant Matheson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-09 | 108,600 | 5.28 | 573,408 |
| TSX:ACQ | AutoCanada Inc | 2022-03-08 | 15,000 | 19.17 | 287,550 |
| TSX:OPT | Optiva Inc | 2021-11-29 | 25,000 | 3.00 | 75,000 |
Holding Weightings of Joseph Lee Grant Matheson
Joseph Lee Grant Matheson Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Lee Grant Matheson has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the sale of 53,700 shares on August 9, 2019, which brought Joseph Lee Grant Matheson around $322,238.
According to the SEC Form 4 filings, Joseph Lee Grant Matheson has made a total of 2 transactions in AutoCanada Inc (TSX:ACQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in AutoCanada Inc is the acquisition of 5,000 shares on March 8, 2022, which cost Joseph Lee Grant Matheson around $141,550.
According to the SEC Form 4 filings, Joseph Lee Grant Matheson has made a total of 1 transactions in Optiva Inc (TSX:OPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Optiva Inc is the acquisition of 25,000 shares on November 29, 2021, which cost Joseph Lee Grant Matheson around $500,000.
Insider Trading History of Joseph Lee Grant Matheson
- 1
Joseph Lee Grant Matheson Trading Performance
GuruFocus tracks the stock performance after each of Joseph Lee Grant Matheson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Lee Grant Matheson is 4.53%. GuruFocus also compares Joseph Lee Grant Matheson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Lee Grant Matheson within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Lee Grant Matheson's insider trading performs compared to the benchmark.
Performance of Joseph Lee Grant Matheson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.22 | | | | | |
| Relative Return to S&P 500(%) | 15.32 | | | | | |
Joseph Lee Grant Matheson Ownership Network
Ownership Network List of Joseph Lee Grant Matheson
Ownership Network Relation of Joseph Lee Grant Matheson
Joseph Lee Grant Matheson Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Joseph Lee Grant Matheson is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include 10% Security Holder Sime Armoyan , Director & Senior Officer Samira Sakhia , and Senior Officer Amal Khouri .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Joseph Lee Grant Matheson made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 774,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 0 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 120,000 shares, with a net purchase of 120,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,029,000 shares were bought by its insiders, resulting in a net purchase of 714,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Joseph Lee Grant Matheson Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Lee Grant Matheson. Currently GuruFocus does not have mailing address information for Joseph Lee Grant Matheson.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
